Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Neuro-Oncology|March 6, 2013
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma modelKenichiro Iwami, Atsushi Natsume, Masasuke Ohno, et al.Cancer Science|September 7, 2023
T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host diseaseSatomi Okada, Daisuke Muraoka, Kiyoshi Yasui, et al.Blood|May 4, 2013
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemiaYukihiro Miyazaki, Hiroshi Fujiwara, Hiroaki Asai, et al.Plos One|February 27, 2013
Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptorHiroaki Asai, Hiroshi Fujiwara, Jun An, et al.Cancer Science|September 29, 2011
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull miceYoshitaka Shirakura, Yukari Mizuno, Linan Wang, et al.Cancer Immunology Research|April 30, 2014
Gene-modified human α/β-T cells expressing a chimeric CD16-CD3ζ receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapyFumihiro Ochi, Hiroshi Fujiwara, Kazushi Tanimoto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2016
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell LeukemiaHiroki Tanaka, Hiroshi Fujiwara, Fumihiro Ochi, et al.International Journal of Hematology|January 14, 2011
Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosisJun An, Hiroshi Fujiwara, Koichiro Suemori, et al.International Journal of Molecular Sciences|July 14, 2023
CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive ImmunotherapyYizheng Wang, Linan Wang, Naohiro Seo, et al.Journal of Translational Medicine|August 26, 2015
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancerNaoyuki Sakamoto, Takeshi Ishikawa, Satoshi Kokura, et al.Pageof 6